Status:

Do Not Prescribe (DNP)

Decision Date:

June 2022

Comments

NICE TA790 - TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)

Do Not Prescribe (DNP) Drug Classifications

• 2: Have a lack of data on safety compared with standard therapy
• 5: Less cost-effective than current standard therapy
• 6: Have NICE guidance that recommends they should not be used

search again